CARRIE MCGUIRE: Open Payments
NPI 1649558941 · ASHLAND, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$729 in 52 payments from 9 companies in 2025. Trend: 2023 $599 · 2024 $1,080 · 2025 $729
Food & beverage: $729
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $183 |
| Otsuka America Pharmaceutical, Inc. | 13 | $145 |
| Lundbeck LLC | 5 | $97 |
| Janssen Pharmaceuticals, Inc | 4 | $83 |
| Alkermes, Inc. | 4 | $78 |
| Axsome Therapeutics, Inc. | 3 | $61 |
| E.R. Squibb & Sons, L.L.C. | 1 | $34 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $31 |
| Teva Pharmaceuticals USA, Inc. | 1 | $17 |
Products named: VRAYLAR, REXULTI, ARISTADA, Auvelity, INVEGA SUSTENNA, ABILIFY MAINTENA, ABILIFY ASIMTUFII, COBENFY.
Industry payments across KY — which companies pay providers there.
